Cell signalling is used to study pathways of cells in drug discovery and therapeutic development. It is a complex process of communication which rules the basic activities of cells and coordinates cell actions to decide drug resistance patterns in cancerous cells. Global cell signalling market value is projected to be $2.53 Billion in 2017 and is expected to generate revenue of around $4.08 Billion by the end of 2024, growing at a CAGR of around 6.8% between 2017 and 2024. The growth of end-use industries and rising incidence of chronic diseases are the factors enhancing the growth of the market. Complexities related to antibody and reagent development and the high cost of cell signalling systems are the factors which hamper the market growth. Emerging markets and emergence of microfluidics in cell biology research are the opportunities for cell signalling market.
Research Study Objectives:
- Define, estimate, and forecast the cell signalling market statistics by application, pathway, signaling type, product, application and regions concerning the individual growth drivers, market trends and their contribution toward the cell signalling market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the cell signalling market analysis report.
- Analysis and conclusions on the future cell signalling market outlook.
Top-down and bottom-up approaches are used to validate the cell signalling market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources;
databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The cell signalling market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the cell signalling market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Cell signalling market segmentation is as follows:
By Signalling Type
- Endocrine signalling
- Paracrine signalling
- Autocrine signalling
- Juxtacrine signalling
- Other signalling types
By Product
By Technology
- Microscopy
- Flow Cytometry
- Mass spectrometry
- Western blotting
- Elisa
- Immunohistochemistry
- Other technologies
By Pathway
- AKT signalling pathway
- AMPK signalling pathway
- ErbB/HER signalling pathway
- Hedgehog signalling pathway
- JAK/STAT signalling pathway
- Notch signalling pathway
- NF-KB signalling pathway
- Other signalling pathways
By Application
- Research applications
- Medical applications
Geographical Analysis:
Cell signalling market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand,
Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the cell signalling market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Cell signalling Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant cell signaling market players, such as
- Beckman Coulter Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories Inc.
- Cell Signaling Technology Inc.
- The Merck Group.
- Along with these companies, many other companies are considered in the report while analysing the global cell signalling competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
